Figure 8. Prediction of response to chemotherapeutics drugs in LGG subtypes. (A–D) Effects of the PI3K/AKT inhibitors AS605240 (A), ZSTK474 (B), A-443654 (C), and AKT inhibitor VIII (D). (E, F) Effects of the MAPK inhibitors NG-25 (E) and TAK-715 (F). (G, H) Effects of the NF kappaB inhibitors embelin (G) and shikonin (H).